PHILLIP MD ET AL FROST Insider Trading $PLX Protalix BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PHILLIP MD ET AL FROST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILLIP MD ET AL FROST. PHILLIP MD ET AL FROST is 10% Owner in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and 10% Owner in TRANSENTERIX INC. ($TRXC) and Director in TRANSENTERIX INC. ($TRXC) and CEO & Chairman in Opko Health, Inc. ($EXEG) and Director in CONTINUCARE CORP ($CNU) and 10% Owner in Protalix BioTherapeutics, Inc. ($PLX) and Director in LADENBURG THALMANN FINANCIAL SERVICES INC ($LTS) and Director in PROLOR Biotech, Inc. ($PBTH).
PHILLIP MD ET AL FROST in Protalix BioTherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PHILLIP MD ET AL FROST: 10% Owner
Holdings: 9,781,273 shares
Current Value: $7,727,206
Latest Transaction: Oct 14 2008
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PHILLIP MD ET AL FROST in Protalix BioTherapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TRXC, CNU, LTS, NIMU, EXEG, PBTH, PLX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.66 | 1,000 | 1,660 | 9,781,273 | 9.8 M to 9.8 M (+0.01 %) |
| Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.64 | 2,500 | 4,100 | 9,780,273 | 9.8 M to 9.8 M (+0.03 %) |
| Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.63 | 600 | 978 | 9,777,773 | 9.8 M to 9.8 M (+0.01 %) |
| Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.62 | 900 | 1,458 | 9,777,173 | 9.8 M to 9.8 M (+0.01 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.94 | 2,500 | 7,350 | 9,776,273 | 9.8 M to 9.8 M (+0.03 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.92 | 1,000 | 2,920 | 9,773,773 | 9.8 M to 9.8 M (+0.01 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.91 | 3,000 | 8,730 | 9,772,773 | 9.8 M to 9.8 M (+0.03 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.90 | 700 | 2,030 | 9,769,773 | 9.8 M to 9.8 M (+0.01 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.89 | 800 | 2,312 | 9,769,073 | 9.8 M to 9.8 M (+0.01 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.87 | 1,400 | 4,018 | 9,768,273 | 9.8 M to 9.8 M (+0.01 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.85 | 300 | 855 | 9,766,873 | 9.8 M to 9.8 M (0.00 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.84 | 100 | 284 | 9,766,573 | 9.8 M to 9.8 M (0.00 %) |
| Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.83 | 200 | 566 | 9,766,473 | 9.8 M to 9.8 M (0.00 %) |
Page: 1